Clinical trials
Metabolic Diseases trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2010 | 3 |
| 2012 | 1 |
| 2014 | 2 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 5 |
| 2022 | 7 |
| 2023 | 1 |
| 2024 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Terminated | 6 |
| Recruiting | 5 |
| Active, not recruiting | 4 |
| Suspended | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Maastricht University Medical Center | 4 |
| 89bio, Inc. | 2 |
| Agios Pharmaceuticals, Inc. | 2 |
| Amgen | 2 |
| Calcilytix Therapeutics, Inc., a BridgeBio company | 2 |
| Diamyd Medical AB | 2 |
| Eli Lilly and Company | 2 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2 |
| Kastle Therapeutics, LLC | 2 |
| ModernaTX, Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Metabolic Diseases | 35 |
| Genetic Diseases, Inborn | 9 |
| Glucose Metabolism Disorders | 7 |
| Metabolism, Inborn Errors | 7 |
| Endocrine System Diseases | 6 |
| Diabetes Mellitus | 5 |
| Lipid Metabolism Disorders | 5 |
| Obesity | 5 |
| Diabetes Mellitus, Type 1 | 4 |
| Diabetes Mellitus, Type 2 | 4 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.